“…Transient, bioresorbable IMDs, which are designed to degrade and be absorbed by the human body over time, have emerged as an attractive new class of biomedical devices. − Their self-clearing capabilities reduce physical and economic burdens on the patients through periodic replacement to extract the device and allow us to circumvent the potential risks for infection and negative health consequences. ,,− Conventional semipermanent IMDs rarely offer a clinical functionality that takes a short time to manage and treat (e.g., neurostimulation for six months and wound healing for two weeks), since the threat of surgery is much greater than their benefits. ,− In this regard, the use of transient IMDs has broadened the scope of medical applications for IMDs to drug delivery, − monitoring, ,,,,− diagnosis, , and therapeutic applications. ,,, Further advances in materials science have led to the rise of on-demand transient IMDs whose degradation starts by events triggered at the intended time. ,,− While a majority of transient systems employ a passive operation that decays constituent materials gradually in vivo, ,,,− this new class of bioresorbable IMDs with active operation is disintegrated quickly after the application of a corresponding stimulus, ensuring their stable function and avoiding the potential risk of residue materials remaining in the body. ,,,− Continued advances in functional polymers, materials processing, and electronic components will drive progress in IMDs with biosafety and complex capabilities for a variety of ...…”